Takeda Pharmaceutical Co.

Takeda Pharmaceutical Co. is a pharmaceutical corporation headquartered in Osaka, Japan, with more than 30,000 employees. It is as of 2012 the largest Japanese pharmaceutical corporation, and the 14th pharmaceutical corporation in the world in terms of global sales. Takeda’s pharmaceutical products are divided among the core therapeutic areas: cardiovascular and metabolic conditions, oncology, the central nervous system, immunology and respiratory conditions, general medicine, and vaccines. Main products in terms of turnover include Actos (marketed as Glustin in Europe) and pioglitazone hydrochloride for the treatment of type 2 diabetes. It was first registered in 1999 and has since been selling in relatively large volumes, including in 2011 when it accounted for approximately 27 percent of the corporation’s revenues. However, it lost its exclusivity in August ...